Cancer research has come a long way over the years. Some of the most advanced medications are being presented to help lower the mortality rate. These powerful new medications come in the form of antibody based-therapies, and they are changing the game for the better. Seattle Genetics, located in Bothell, Washington, is the worldwide leader in cancer research. This organization has been around since the late 1990s, but success didn’t actually come from its moment of inception. Thanks to having such great leadership in place, Seattle Genetics was able to dig itself out of the hole and the rest was history.
CEO Clay Siegall has provided this great leadership, and he has the experience to do so because he understands the business more so than anyone else. Siegall is also one of the company’s founders, and he serves as the current president. Siegall was able to bring in an experienced sales team. This team of individuals all had a deep understanding of biotech and the products that were being produced. Since that point in time from the early 2000s, Seattle Genetics has dramatically grown in profits, in personnel and in size. As of today, the company has well over 1,000 employees, and it is one of the area’s largest employers. On the other hand, Siegall has applied his business principles to the company’s blueprint. Drug development, rigorous research and scientific innovation. These principles are the keys to success and no other organization in this field can do it any better.
Clay Siegall does a bit of blogging in his free time. He speaks on a wide range of topics such as industry news to current news events. After all of these years, he still isn’t showing any signs of slowing down. This is because of the burning passion that’s within is soul. He has seen first-hand how devastating cancer can be. The future of cancer research seems to be in pretty good hands and Dr. Clay Siegall is playing a key role.